Paper32175692
Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma.
Song S and 14 others. Mol Oncol, 2020. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma. Papers, record 32175692. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32175692
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adaptor Proteins, Signal Transducing | Major topic |
| Adenocarcinoma | Major topic |
| Azepines | Major topic |
| Cell Cycle Proteins | Major topic |
| Esophageal Neoplasms | Major topic |
| Protein Serine-Threonine Kinases | Major topic |
| Transcription Factors | Major topic |
| Triazoles | Major topic |
| Animals | |
| Antineoplastic Agents | |
| Carcinogenesis | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Docetaxel | |
| Drug Resistance, Neoplasm | |
| Hippo Signaling Pathway | |
| Humans | |
| Mice, Nude | |
| Neoplastic Stem Cells | |
| Promoter Regions, Genetic | |
| Transcription, Genetic | |
| YAP-Signaling Proteins | |
| Bromodomain Containing Proteins |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA016672 | NCI NIH HHS | United States | P30CA016672 | PubMed and NIH | NIH RePORTER |
| R21 CA129906 | NCI NIH HHS | United States | R21CA129906 | PubMed and NIH | NIH RePORTER |
| R01 CA160433 | NCI NIH HHS | United States | R01CA160433 | PubMed and NIH | NIH RePORTER |
| R01 CA172741 | NCI NIH HHS | United States | R01CA172741 | PubMed and NIH | NIH RePORTER |
| R01 CA138671 | NCI NIH HHS | United States | R01CA138671 | PubMed and NIH | NIH RePORTER |
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25506891 | Twist-BRD4 complex: potential drug target for basal-like breast cancer. | Curr Pharm Des | 2015 | https://conductscience.org/library/papers/25506891 | PubMed |
| 2 | 28728163 | Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients. | Br J Cancer | 2017 | https://conductscience.org/library/papers/28728163 | PubMed |
| 3 | 26667886 | Global Cancer Incidence and Mortality Rates and Trends--An Update. | Cancer Epidemiol Biomarkers Prev | 2016 | https://conductscience.org/library/papers/26667886 | PubMed |
| 4 | 25711863 | YAP and the drug resistance highway. | Nat Genet | 2015 | https://conductscience.org/library/papers/25711863 | PubMed |
| 5 | 22575479 | Organ size control by Hippo and TOR pathways. | Curr Biol | 2012 | https://conductscience.org/library/papers/22575479 | PubMed |
| 6 | 26544935 | Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer. | Cell | 2015 | https://conductscience.org/library/papers/26544935 | PubMed |
| 7 | 17329240 | The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17329240 | PubMed |
| 8 | 26830473 | BET protein inhibitor JQ1 inhibits growth and modulates WNT signaling in mesenchymal stem cells. | Stem Cell Res Ther | 2016 | https://conductscience.org/library/papers/26830473 | PubMed |
| 9 | 17980593 | YAP1 increases organ size and expands undifferentiated progenitor cells. | Curr Biol | 2007 | https://conductscience.org/library/papers/17980593 | PubMed |
| 10 | 28681984 | BRD4 promotes gastric cancer progression through the transcriptional and epigenetic regulation of c-MYC. | J Cell Biochem | 2018 | https://conductscience.org/library/papers/28681984 | PubMed |
| 11 | 24882516 | Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP. | Cancer Cell | 2014 | https://conductscience.org/library/papers/24882516 | PubMed |
| 12 | 22722403 | BET domain co-regulators in obesity, inflammation and cancer. | Nat Rev Cancer | 2012 | https://conductscience.org/library/papers/22722403 | PubMed |
| 13 | 24694946 | Identification, mechanism of action, and antitumor activity of a small molecule inhibitor of hippo, TGF-β, and Wnt signaling pathways. | Mol Cancer Ther | 2014 | https://conductscience.org/library/papers/24694946 | PubMed |
| 14 | 27294782 | Functional interdependence of BRD4 and DOT1L in MLL leukemia. | Nat Struct Mol Biol | 2016 | https://conductscience.org/library/papers/27294782 | PubMed |
| 15 | 29167315 | A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma. | Mol Cancer Ther | 2018 | https://conductscience.org/library/papers/29167315 | PubMed |
| 16 | 22863277 | Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. | Cell | 2012 | https://conductscience.org/library/papers/22863277 | PubMed |
| 17 | 19141641 | Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein. | Cancer Res | 2009 | https://conductscience.org/library/papers/19141641 | PubMed |
| 18 | 24973920 | Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition. | Nat Med | 2014 | https://conductscience.org/library/papers/24973920 | PubMed |
| 19 | 18223296 | The bromodomain protein Brd4 stimulates G1 gene transcription and promotes progression to S phase. | J Biol Chem | 2008 | https://conductscience.org/library/papers/18223296 | PubMed |
| 20 | 30224758 | Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4. | Nat Med | 2018 | https://conductscience.org/library/papers/30224758 | PubMed |
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42441024 | YAP1 depletion enhances TAZ and its complexation with TEAD4 and AP-1 heterodimer C-JUN/FOSB in gastric cancer progression and metastasis. | Cancer Heterog Plast | 2026 | https://conductscience.org/library/papers/42441024 | PubMed |
| 42287329 | The Hippo signaling pathway in pediatric brain tumors: molecular mechanisms and therapeutic opportunities. | Cancer Metastasis Rev | 2026 | https://conductscience.org/library/papers/42287329 | PubMed |
| 41901316 | From Environmental Risk to Cancer Stemness: Epigenetic Regulation in Oral Squamous Cell Carcinoma. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41901316 | PubMed |
| 41364143 | Bromodomain-Driven Regulation of Stem Cells: A Potential Target for Cancer Therapeutic Intervention. | Stem Cell Rev Rep | 2026 | https://conductscience.org/library/papers/41364143 | PubMed |
| 41184230 | Inhibition of BRD4 sensitizes NSCLC cells to osimertinib by suppressing APT1 and promoting MST1 palmitoylation. | Cell Death Discov | 2025 | https://conductscience.org/library/papers/41184230 | PubMed |
| 40723817 | Recent Advances in Combination Therapy of YAP Inhibitors with Physical Anti-Cancer Strategies. | Biomolecules | 2025 | https://conductscience.org/library/papers/40723817 | PubMed |
| 40699696 | The Mechanical Role of YAP/TAZ in the Development of Diabetic Cardiomyopathy. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40699696 | PubMed |
| 40682837 | Changing landscape of advanced esophageal squamous cell carcinoma: Breakthroughs in systemic therapies (Review). | Oncol Rep | 2025 | https://conductscience.org/library/papers/40682837 | PubMed |
| 39702340 | BET inhibition revealed varying MYC dependency mechanisms independent of gene alterations in aggressive B-cell lymphomas. | Clin Epigenetics | 2024 | https://conductscience.org/library/papers/39702340 | PubMed |
| 39603381 | HSP90 inhibitor AUY922 suppresses tumor growth and modulates immune response through YAP1-TEAD pathway inhibition in gastric cancer. | Cancer Lett | 2025 | https://conductscience.org/library/papers/39603381 | PubMed |
| 39219068 | An updated patent review of BRD4 degraders. | Expert Opin Ther Pat | 2024 | https://conductscience.org/library/papers/39219068 | PubMed |
| 38424512 | Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer. | J Transl Med | 2024 | https://conductscience.org/library/papers/38424512 | PubMed |
| 38169595 | Combined BET and MEK Inhibition synergistically suppresses melanoma by targeting YAP1. | Theranostics | 2024 | https://conductscience.org/library/papers/38169595 | PubMed |
| 37994501 | The potential of BRD4 inhibition in tumour mechanosignaling. | J Cell Mol Med | 2023 | https://conductscience.org/library/papers/37994501 | PubMed |
| 37953273 | Transcriptional co-activators: emerging roles in signaling pathways and potential therapeutic targets for diseases. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37953273 | PubMed |
| 37338772 | Targeting epigenetic deregulations for the management of esophageal carcinoma: recent advances and emerging approaches. | Cell Biol Toxicol | 2023 | https://conductscience.org/library/papers/37338772 | PubMed |
| 37319316 | Chaetocin exhibits anticancer effects in esophageal squamous cell carcinoma via activation of Hippo pathway. | Aging (Albany NY) | 2023 | https://conductscience.org/library/papers/37319316 | PubMed |
| 36674511 | Bromodomain (BrD) Family Members as Regulators of Cancer Stemness-A Comprehensive Review. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36674511 | PubMed |
| 36418715 | The Interaction Between SMAD1 and YAP1 Is Correlated with Increased Resistance of Gastric Cancer Cells to Cisplatin. | Appl Biochem Biotechnol | 2023 | https://conductscience.org/library/papers/36418715 | PubMed |
| 36387198 | Super-enhancers in esophageal carcinoma: Transcriptional addictions and therapeutic strategies. | Front Oncol | 2022 | https://conductscience.org/library/papers/36387198 | PubMed |
Genes29
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32175692
GET https://conductscience.org/api/papers/v1/32175692/references?page=2